HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Catherine A Rugg Selected Research

JNJ 28871063

2/2008Cellular and in vivo activity of JNJ-28871063, a nonquinazoline pan-ErbB kinase inhibitor that crosses the blood-brain barrier and displays efficacy against intracranial tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Catherine A Rugg Research Topics

Disease

3Neoplasms (Cancer)
02/2008 - 10/2005
1Carcinoma (Carcinomatosis)
10/2006
1Retinoblastoma (Glioblastoma, Retinal)
10/2005
1Melanoma (Melanoma, Malignant)
06/2005

Drug/Important Bio-Agent (IBA)

2JNJ-7706621IBA
10/2006 - 10/2005
2Cyclin-Dependent Kinases (cdk Proteins)IBA
10/2006 - 10/2005
2aurora kinase (aurora A kinase)IBA
10/2006 - 10/2005
1JNJ 28871063IBA
02/2008
1Phosphotransferases (Kinase)IBA
02/2008
1Tyrosine (L-Tyrosine)FDA Link
02/2008
1CDC2 Protein Kinase (Protein p34cdc2)IBA
10/2005
1P-GlycoproteinIBA
10/2005

Therapy/Procedure

4Heterologous Transplantation (Xenotransplantation)
02/2008 - 06/2005